GLS-010 Monotherapy Versus Chemotherapy in Patients With Relapsed or Refractory Classical Hodgkin's Lymphoma (R/R cHL)

NCT05518318 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Classic Hodgkin's Lymphoma
Recurrent Classic Hodgkin Lymphoma
Refractory Classic Hodgkin Lymphoma

Interventions

DRUG: GLS-010
DRUG: Chemotherapy of Investigator's choice

Sponsor

Guangzhou Gloria Biosciences Co., Ltd.